Skip to main content
. 2020 Jun 30;20:609. doi: 10.1186/s12885-020-07104-9

Table 1.

Cancer and chemotherapeutic parameters

All (n = 43) non-CTRCD (n = 37) CTRCD (n = 6)
Soft Tissue Sarcoma (n, %) 31 (72) 27 (72) 4 (67)
Metastatic (n, %) 26 (60) 21 (57) 5 (83)
Anthracycline dose mg/m2 (mean, SD) 337(±159) 328(±149) 388(±223)
Dexrazoxane (n, %) 25 (58) 21 (57) 4 (67)
Ifosfamide (n, %) 25 (58) 19 (51) 6 (100)

CTRCD cancer therapeutics related cardiac dysfunction, SD standard deviation